Geigert. (2013). The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics (2.). Springer New York.
Chicago-viite (17. p.)Geigert. The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics. 2. Springer New York, 2013.
MLA-viite (8. p.)Geigert. The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics. 2. Springer New York, 2013.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.